-
Mashup Score: 3Ide-cel Leads to High Real-World Remission Rates in CNS Myeloma - 8 hour(s) ago
In a retrospective cohort of patients with central nervous system manifestations of multiple myeloma, ide-cel CAR T-cell therapy was effective.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 23Vincent Rajkumar: from Madras to Minnesota for myeloma - 18 hour(s) ago
Challenging assumptions seems to be in the blood of Vincent Rajkumar. Take his taste in music. Cerebral, temperate, and mild-mannered are the adjectives that spring immediately to mind as he talks fondly about his day-to-day life as Professor of Medicine and Chair of the Myeloma Amyloidosis Dysproteinemia Group at the Mayo Clinic, Rochester, MN, USA. The Lancet automatically assumed that opera, classical, or perhaps jazz would figure heavily as the conversation turned to music. But then he drops the bombshell: “I’m a major Megadeth fan”.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Using bispecific antibodies before or after CAR T-cell therapy in multiple myeloma is an area of education for community oncologists.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
PFS and OS were significantly improved with subcutaneous daratumumab vs active monitoring in patients with smoldering multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2
Daratumumab plus VRd showed a deepened MRD and PFS rate for patients with transplant-ineligible or -deferred newly diagnosed multiple myeloma.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 20Transplant in myeloma: who, when, and why? - 3 day(s) ago
Abstract. High-dose melphalan supported by autologous transplantation has been the standard of care for eligible patients with newly diagnosed multiple mye
Source: ashpublications.orgCategories: General Medicine News, PediatricsTweet
-
Mashup Score: 1
Abstract. Significant progress has been made in the treatment of multiple myeloma (MM), with the introduction of several new drugs with different mechanism
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 27Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages - 24 day(s) ago
Blood Cancer Journal – Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Check our recent publication: Multi-omics reveal immune microenvironment alterations in MM and its precursor stages #mmsm #ASH24 ➡️ https://t.co/vkqWZVETre MGUS/SMM➡️MM ✅decrease in granulocytes ✅changes in NK&CD8 T cell phenotypes ✅increased inhibitory markers (TIM3, TIGIT). https://t.co/XLvcJHNDlg
-
Patients treated with ide-cel for R/R multiple myeloma affecting the central nervous system responded favorably and had similar outcomes to matched patients with non-CNS multiple myeloma. #MMSM #ASH24 https://t.co/6bPWrnlf8u https://t.co/SXe6iJKFKw